The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer.

Tuba KarpuzMurat ArazLevent KorkmazIbrahim KılıncSidika FindikMustafa KaraagaçMelek Karakurt EryilmazMehmet Artac

Published in: Journal of gastrointestinal cancer (2021)

Pre-treatment semaphorin 3A level can be a prognostic marker for the mCRC patients who were treated with bevacizumab in patients with metastatic colorectal cancer.

Keyphrases

metastatic colorectal cancer
endothelial cells
vascular endothelial growth factor
combination therapy
newly diagnosed